Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 13 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

human papillomavirus vaccine, L1 type 16, 18 40 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 32 Papillomavirus Vaccines 24 Human Papillomavirus Recombinant Vaccine nonavalent 12 Vaccines 11 Blood Specimen Collection 10 Data Collection 9 Colposcopy 9 Human Papillomavirus DNA Tests 8 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Cisplatin 7 Surveys and Questionnaires 6 Educational Status 6 Early Intervention, Educational 6 Carboplatin 6 Vaginal Smears 5 Vaccines, Synthetic 5 Methods 5 Engerix-B 4 fludarabine 3 epigallocatechin gallate 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Polymerase Chain Reaction 3 Patient Navigation 3 Paclitaxel 3 Observation 3 Mass Screening 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Sodium Chloride × Clear all

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡